0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Kidney Cancer Market Research Report 2024
Published Date: January 2025
|
Report Code: QYRE-Auto-38R2107
Home | Market Reports | Health| Health Conditions| Cancer
Global Kidney Cancer Market Insights Forecast to 2028
BUY CHAPTERS

Global Kidney Cancer Market Research Report 2024

Code: QYRE-Auto-38R2107
Report
January 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Kidney Cancer Market Size

The global market for Kidney Cancer was valued at US$ 10830 million in the year 2023 and is projected to reach a revised size of US$ 16630 million by 2030, growing at a CAGR of 6.3% during the forecast period.

Kidney Cancer Market

Kidney Cancer Market

Kidney cancer therapy refers to a range of medical treatments aimed at managing or eradicating cancerous cells in the kidneys. These treatments include surgery (such as nephrectomy), targeted therapy, immunotherapy, radiation therapy, and, in some cases, chemotherapy. The choice of therapy depends on the type, stage, and progression of the cancer, as well as the patient’s overall health. The primary goals are to control the disease, prolong survival, and improve the patient’s quality of life.
Market Drivers for Kidney Cancer:
Increasing Prevalence of Kidney Cancer: Rising cases of kidney cancer worldwide, driven by aging populations and lifestyle-related factors, are boosting the demand for effective diagnostic and therapeutic solutions.
Advancements in Treatment Options: Innovations in targeted therapies, immunotherapies, and minimally invasive surgical techniques are improving patient outcomes, driving market growth.
Growing Awareness and Early Diagnosis: Enhanced awareness campaigns and improved screening technologies are leading to earlier detection, which increases the demand for treatments.
Supportive Government Policies and Funding: Increased investments in cancer research and supportive healthcare policies are fostering market expansion.
Market Challenges for Kidney Cancer:
High Treatment Costs: The expensive nature of advanced therapies, including immunotherapy and targeted drugs, limits accessibility for some patients, particularly in developing regions.
Side Effects and Resistance to Therapies: Adverse effects of treatments and the potential development of resistance to targeted drugs pose significant clinical and market challenges.
Limited Accessibility in Low-Income Regions: Inadequate healthcare infrastructure and limited access to advanced treatments in certain regions hinder market penetration.
Regulatory Hurdles: Stringent regulatory requirements for the approval of new drugs and therapies may delay market entry and development.
Global key players of Kidney Cancer include Pfizer, Exelixis, Bristol-Myers Squibb, Novartis, etc. Global top four manufacturers hold a share over 35%. North America has the largest number of Kidney cancer, holds a share of about 50%. In terms of product, targeted therapy is the largest segment, with a share over 45%. And in terms of application, the largest application is renal cell carcinoma, with a share of over 90%.
This report aims to provide a comprehensive presentation of the global market for Kidney Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer.
The Kidney Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Kidney Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Kidney Cancer Market Report

Report Metric Details
Report Name Kidney Cancer Market
Accounted market size in year US$ 10830 million
Forecasted market size in 2030 US$ 16630 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2030
Segment by Type
  • Surgery
  • Immunotherapy
  • Targeted Therapy
  • Other
Segment by Application
  • Renal Cell Carcinoma
  • Renal Pelvis Cancer
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer, Exelixis, Eisai, Hikma Pharmaceuticals, Sun Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Kidney Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Kidney Cancer Market growing?

Ans: The Kidney Cancer Market witnessing a CAGR of 6.3% during the forecast period 2025-2030.

What is the Kidney Cancer Market size in 2030?

Ans: The Kidney Cancer Market size in 2030 will be US$ 16630 million.

What is the market share of major companies in Kidney Cancer Market?

Ans: Global top four manufacturers hold a share over 35%.

What is the Kidney Cancer Market share by region?

Ans: North America has the largest number of Kidney cancer, holds a share of about 50%.

What is the Kidney Cancer Market share by type?

Ans: In terms of product, targeted therapy is the largest segment, with a share over 45%.

What is the Kidney Cancer Market share by application?

Ans: And in terms of application, the largest application is renal cell carcinoma, with a share of over 90%.

Who are the main players in the Kidney Cancer Market report?

Ans: The main players in the Kidney Cancer Market are Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer, Exelixis, Eisai, Hikma Pharmaceuticals, Sun Pharmaceutical

What are the Application segmentation covered in the Kidney Cancer Market report?

Ans: The Applications covered in the Kidney Cancer Market report are Renal Cell Carcinoma, Renal Pelvis Cancer, Other

What are the Type segmentation covered in the Kidney Cancer Market report?

Ans: The Types covered in the Kidney Cancer Market report are Surgery, Immunotherapy, Targeted Therapy, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgery
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Kidney Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Renal Cell Carcinoma
1.3.3 Renal Pelvis Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kidney Cancer Market Perspective (2019-2030)
2.2 Global Kidney Cancer Growth Trends by Region
2.2.1 Global Kidney Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Kidney Cancer Historic Market Size by Region (2019-2024)
2.2.3 Kidney Cancer Forecasted Market Size by Region (2025-2030)
2.3 Kidney Cancer Market Dynamics
2.3.1 Kidney Cancer Industry Trends
2.3.2 Kidney Cancer Market Drivers
2.3.3 Kidney Cancer Market Challenges
2.3.4 Kidney Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer Players by Revenue
3.1.1 Global Top Kidney Cancer Players by Revenue (2019-2024)
3.1.2 Global Kidney Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Kidney Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Kidney Cancer Revenue
3.4 Global Kidney Cancer Market Concentration Ratio
3.4.1 Global Kidney Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Revenue in 2023
3.5 Global Key Players of Kidney Cancer Head office and Area Served
3.6 Global Key Players of Kidney Cancer, Product and Application
3.7 Global Key Players of Kidney Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney Cancer Breakdown Data by Type
4.1 Global Kidney Cancer Historic Market Size by Type (2019-2024)
4.2 Global Kidney Cancer Forecasted Market Size by Type (2025-2030)
5 Kidney Cancer Breakdown Data by Application
5.1 Global Kidney Cancer Historic Market Size by Application (2019-2024)
5.2 Global Kidney Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Kidney Cancer Market Size (2019-2030)
6.2 North America Kidney Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Kidney Cancer Market Size by Country (2019-2024)
6.4 North America Kidney Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Kidney Cancer Market Size (2019-2030)
7.2 Europe Kidney Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Kidney Cancer Market Size by Country (2019-2024)
7.4 Europe Kidney Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Kidney Cancer Market Size (2019-2030)
8.2 Asia-Pacific Kidney Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Kidney Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Kidney Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Kidney Cancer Market Size (2019-2030)
9.2 Latin America Kidney Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Kidney Cancer Market Size by Country (2019-2024)
9.4 Latin America Kidney Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney Cancer Market Size (2019-2030)
10.2 Middle East & Africa Kidney Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Kidney Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Kidney Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Kidney Cancer Introduction
11.1.4 Merck Revenue in Kidney Cancer Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Kidney Cancer Introduction
11.2.4 Novartis Revenue in Kidney Cancer Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Kidney Cancer Introduction
11.3.4 Bristol-Myers Squibb Revenue in Kidney Cancer Business (2019-2024)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Kidney Cancer Introduction
11.4.4 Pfizer Revenue in Kidney Cancer Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Kidney Cancer Introduction
11.5.4 Roche Revenue in Kidney Cancer Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Kidney Cancer Introduction
11.6.4 Amgen Revenue in Kidney Cancer Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 Aveo Pharmaceuticals
11.7.1 Aveo Pharmaceuticals Company Details
11.7.2 Aveo Pharmaceuticals Business Overview
11.7.3 Aveo Pharmaceuticals Kidney Cancer Introduction
11.7.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2019-2024)
11.7.5 Aveo Pharmaceuticals Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Kidney Cancer Introduction
11.8.4 Bayer Revenue in Kidney Cancer Business (2019-2024)
11.8.5 Bayer Recent Development
11.9 Exelixis
11.9.1 Exelixis Company Details
11.9.2 Exelixis Business Overview
11.9.3 Exelixis Kidney Cancer Introduction
11.9.4 Exelixis Revenue in Kidney Cancer Business (2019-2024)
11.9.5 Exelixis Recent Development
11.10 Eisai
11.10.1 Eisai Company Details
11.10.2 Eisai Business Overview
11.10.3 Eisai Kidney Cancer Introduction
11.10.4 Eisai Revenue in Kidney Cancer Business (2019-2024)
11.10.5 Eisai Recent Development
11.11 Hikma Pharmaceuticals
11.11.1 Hikma Pharmaceuticals Company Details
11.11.2 Hikma Pharmaceuticals Business Overview
11.11.3 Hikma Pharmaceuticals Kidney Cancer Introduction
11.11.4 Hikma Pharmaceuticals Revenue in Kidney Cancer Business (2019-2024)
11.11.5 Hikma Pharmaceuticals Recent Development
11.12 Sun Pharmaceutical
11.12.1 Sun Pharmaceutical Company Details
11.12.2 Sun Pharmaceutical Business Overview
11.12.3 Sun Pharmaceutical Kidney Cancer Introduction
11.12.4 Sun Pharmaceutical Revenue in Kidney Cancer Business (2019-2024)
11.12.5 Sun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Kidney Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Surgery
 Table 3. Key Players of Immunotherapy
 Table 4. Key Players of Targeted Therapy
 Table 5. Key Players of Other
 Table 6. Global Kidney Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Kidney Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Kidney Cancer Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global Kidney Cancer Market Share by Region (2019-2024)
 Table 10. Global Kidney Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global Kidney Cancer Market Share by Region (2025-2030)
 Table 12. Kidney Cancer Market Trends
 Table 13. Kidney Cancer Market Drivers
 Table 14. Kidney Cancer Market Challenges
 Table 15. Kidney Cancer Market Restraints
 Table 16. Global Kidney Cancer Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global Kidney Cancer Market Share by Players (2019-2024)
 Table 18. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer as of 2023)
 Table 19. Ranking of Global Top Kidney Cancer Companies by Revenue (US$ Million) in 2023
 Table 20. Global 5 Largest Players Market Share by Kidney Cancer Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of Kidney Cancer, Headquarters and Area Served
 Table 22. Global Key Players of Kidney Cancer, Product and Application
 Table 23. Global Key Players of Kidney Cancer, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Kidney Cancer Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global Kidney Cancer Revenue Market Share by Type (2019-2024)
 Table 27. Global Kidney Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global Kidney Cancer Revenue Market Share by Type (2025-2030)
 Table 29. Global Kidney Cancer Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global Kidney Cancer Revenue Market Share by Application (2019-2024)
 Table 31. Global Kidney Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global Kidney Cancer Revenue Market Share by Application (2025-2030)
 Table 33. North America Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 34. North America Kidney Cancer Market Size by Country (2019-2024) & (US$ Million)
 Table 35. North America Kidney Cancer Market Size by Country (2025-2030) & (US$ Million)
 Table 36. Europe Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. Europe Kidney Cancer Market Size by Country (2019-2024) & (US$ Million)
 Table 38. Europe Kidney Cancer Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Asia-Pacific Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Asia-Pacific Kidney Cancer Market Size by Region (2019-2024) & (US$ Million)
 Table 41. Asia-Pacific Kidney Cancer Market Size by Region (2025-2030) & (US$ Million)
 Table 42. Latin America Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Latin America Kidney Cancer Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Kidney Cancer Market Size by Country (2025-2030) & (US$ Million)
 Table 45. Middle East & Africa Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Middle East & Africa Kidney Cancer Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Middle East & Africa Kidney Cancer Market Size by Country (2025-2030) & (US$ Million)
 Table 48. Merck Company Details
 Table 49. Merck Business Overview
 Table 50. Merck Kidney Cancer Product
 Table 51. Merck Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
 Table 52. Merck Recent Development
 Table 53. Novartis Company Details
 Table 54. Novartis Business Overview
 Table 55. Novartis Kidney Cancer Product
 Table 56. Novartis Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
 Table 57. Novartis Recent Development
 Table 58. Bristol-Myers Squibb Company Details
 Table 59. Bristol-Myers Squibb Business Overview
 Table 60. Bristol-Myers Squibb Kidney Cancer Product
 Table 61. Bristol-Myers Squibb Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
 Table 62. Bristol-Myers Squibb Recent Development
 Table 63. Pfizer Company Details
 Table 64. Pfizer Business Overview
 Table 65. Pfizer Kidney Cancer Product
 Table 66. Pfizer Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
 Table 67. Pfizer Recent Development
 Table 68. Roche Company Details
 Table 69. Roche Business Overview
 Table 70. Roche Kidney Cancer Product
 Table 71. Roche Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
 Table 72. Roche Recent Development
 Table 73. Amgen Company Details
 Table 74. Amgen Business Overview
 Table 75. Amgen Kidney Cancer Product
 Table 76. Amgen Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
 Table 77. Amgen Recent Development
 Table 78. Aveo Pharmaceuticals Company Details
 Table 79. Aveo Pharmaceuticals Business Overview
 Table 80. Aveo Pharmaceuticals Kidney Cancer Product
 Table 81. Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
 Table 82. Aveo Pharmaceuticals Recent Development
 Table 83. Bayer Company Details
 Table 84. Bayer Business Overview
 Table 85. Bayer Kidney Cancer Product
 Table 86. Bayer Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
 Table 87. Bayer Recent Development
 Table 88. Exelixis Company Details
 Table 89. Exelixis Business Overview
 Table 90. Exelixis Kidney Cancer Product
 Table 91. Exelixis Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
 Table 92. Exelixis Recent Development
 Table 93. Eisai Company Details
 Table 94. Eisai Business Overview
 Table 95. Eisai Kidney Cancer Product
 Table 96. Eisai Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
 Table 97. Eisai Recent Development
 Table 98. Hikma Pharmaceuticals Company Details
 Table 99. Hikma Pharmaceuticals Business Overview
 Table 100. Hikma Pharmaceuticals Kidney Cancer Product
 Table 101. Hikma Pharmaceuticals Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
 Table 102. Hikma Pharmaceuticals Recent Development
 Table 103. Sun Pharmaceutical Company Details
 Table 104. Sun Pharmaceutical Business Overview
 Table 105. Sun Pharmaceutical Kidney Cancer Product
 Table 106. Sun Pharmaceutical Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
 Table 107. Sun Pharmaceutical Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Kidney Cancer Picture
 Figure 2. Global Kidney Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Kidney Cancer Market Share by Type: 2023 VS 2030
 Figure 4. Surgery Features
 Figure 5. Immunotherapy Features
 Figure 6. Targeted Therapy Features
 Figure 7. Other Features
 Figure 8. Global Kidney Cancer Market Size by Application (2024-2030) & (US$ Million)
 Figure 9. Global Kidney Cancer Market Share by Application: 2023 VS 2030
 Figure 10. Renal Cell Carcinoma Case Studies
 Figure 11. Renal Pelvis Cancer Case Studies
 Figure 12. Other Case Studies
 Figure 13. Kidney Cancer Report Years Considered
 Figure 14. Global Kidney Cancer Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Kidney Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Kidney Cancer Market Share by Region: 2023 VS 2030
 Figure 17. Global Kidney Cancer Market Share by Players in 2023
 Figure 18. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Kidney Cancer Revenue in 2023
 Figure 20. North America Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Kidney Cancer Market Share by Country (2019-2030)
 Figure 22. United States Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Kidney Cancer Market Share by Country (2019-2030)
 Figure 26. Germany Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Kidney Cancer Market Share by Region (2019-2030)
 Figure 34. China Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Kidney Cancer Market Share by Country (2019-2030)
 Figure 42. Mexico Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Kidney Cancer Market Share by Country (2019-2030)
 Figure 46. Turkey Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Merck Revenue Growth Rate in Kidney Cancer Business (2019-2024)
 Figure 50. Novartis Revenue Growth Rate in Kidney Cancer Business (2019-2024)
 Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Business (2019-2024)
 Figure 52. Pfizer Revenue Growth Rate in Kidney Cancer Business (2019-2024)
 Figure 53. Roche Revenue Growth Rate in Kidney Cancer Business (2019-2024)
 Figure 54. Amgen Revenue Growth Rate in Kidney Cancer Business (2019-2024)
 Figure 55. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2019-2024)
 Figure 56. Bayer Revenue Growth Rate in Kidney Cancer Business (2019-2024)
 Figure 57. Exelixis Revenue Growth Rate in Kidney Cancer Business (2019-2024)
 Figure 58. Eisai Revenue Growth Rate in Kidney Cancer Business (2019-2024)
 Figure 59. Hikma Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2019-2024)
 Figure 60. Sun Pharmaceutical Revenue Growth Rate in Kidney Cancer Business (2019-2024)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pelvic Cancer Drug Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Y19082
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Cancer Treatment Support Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15F18979
Fri Jan 24 00:00:00 UTC 2025

Add to Cart

Global Precision Radiotherapy Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35E18717
Fri Jan 24 00:00:00 UTC 2025

Add to Cart

Global ICIs for Cervical Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35J18661
Thu Jan 23 00:00:00 UTC 2025

Add to Cart